‘Too Rare to Care’? A New Center for Rare Diseases Hopes to Change That
Agenda
A new nonprofit wants to streamline gene therapy for diseases often avoided by pharmaceutical companies — making treatment more like a routine procedure than a bespoke drug.
To read the full story from the source: New York Times – Home
